NBIX vs URBN · P/E 45, rev $1.77B vs P/E 14, rev $6.17B
Neurocrine Biosciences Inc (NBIX) versus Urban Outfitters Inc (URBN) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Urban Outfitters Inc (URBN) is a apparel retail company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported URBN revenue for 2026-01-31 was $6.17B. Net income was $464.9M. Revenue was up 11.1% from 2025-01-31 to 2026-01-31. URBN currently screens at market cap $6.21B and trailing P/E 14.1.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. URBN currently screens at market cap $6.21B and trailing P/E 14.1.
Not investment advice. Open the NBIX and URBN stock pages for the full models.
Not investment advice.